References

• 1998The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-1019,258 cited
• 1959L’examen Clinique en Psychologie3,302 cited
• 2003The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)1,271 cited
• 1998Memory impairment in abstinent MDMA ("Ecstasy") users376 cited
• 1960MEMORY-FOR-DESIGNS TEST: REVISED GENERAL MANUAL361 cited
• 1991[The Dutch Reading Test for Adults: a measure of premorbid intelligence level].335 cited
• 2000(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals292 cited
• 2000The relative contributions of ecstasy and cannabis to cognitive impairment225 cited
• 2006Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?189 cited
• 1998An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine.181 cited
• 2006The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview179 cited
• 2002Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users161 cited
• 2003Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users148 cited
• 2007